PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue52,546,00052,824,00048,851,00049,605,000
Cost of Revenue10,590,00011,925,0009,361,0009,033,000
Gross Profit41,956,00040,899,00039,490,00040,572,000
Operating Expenses
Research Development7,619,0007,838,0007,646,0007,150,000
Selling General and Administrative14,485,00014,748,00014,325,00013,720,000
Non Recurring----
Others----
Total Operating Expenses37,452,00038,567,00035,060,00033,942,000
Operating Income or Loss15,094,00014,257,00013,791,00015,663,000
Income from Continuing Operations
Total Other Income/Expenses Net-2,790,000-5,904,000-4,826,000-3,425,000
Earnings Before Interest and Taxes15,094,00014,257,00013,791,00015,663,000
Interest Expense-1,270,000-1,186,000-1,199,000-1,360,000
Income Before Tax12,304,0008,353,0008,965,00012,238,000
Income Tax Expense-9,049,0001,123,0001,990,0003,120,000
Minority Interest348,000296,000278,000321,000
Net Income From Continuing Ops21,353,0007,230,0006,975,0009,118,000
Non-recurring Events
Discontinued Operations2,00016,00011,00049,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income21,308,0007,215,0006,960,0009,135,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares21,307,0007,214,0006,959,0009,134,000